Journal of Applied Pharmaceutical Science
Pharmacological Management of Dyslipidemia in Obese and Elderly Patients: Challenges, Current Therapies, and Emerging Treatments
ReviewDyslipidemia
Papers on statin + ezetimibe
184 papers62 new in 30 days
Sunday, July 19
Tuesday, July 7
Cardiology in Review
Lipid-Lowering Efficacy and Safety of Obicetrapib Alone and as an Add on Therapy: A Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsObicetrapib
Friday, July 3
Journal of the American Heart Association
Metabolic and Safety Outcomes of Statin-Ezetimibe Versus High-Intensity Statin in Older Patients
Randomized trial in 318 peopleStatins
Monday, June 29
medRxiv
Low-Density Lipoprotein Cholesterol and Dementia Risk: Integrating Mendelian Randomization and Target Trial Emulation Within the Heart-Brain Axis
Preprint: Mendelian randomization in 6,977 peopleDementia with Lewy bodies
Tuesday, June 9
Sunday, June 7
ADA Scientific Sessions 2026 Abstract
PCSK9 Inhibitors Are Associated with a Lower Risk of Incident Diabetes: A Global Real-World Analysis
Cohort study of 27,025 peoplePCSK9 inhibitors
Saturday, June 6
Pharmacological Reviews
Are we underestimating the benefits of lipid-lowering therapies?
ReviewInterventions
Friday, May 1
European Heart Journal Supplements
INCLISIRAN IN TWO VERY–HIGH CV RISK PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
Case seriesInclisiran
Sunday, March 29
Revista Portuguesa de Cardiologia
Lipoprotein(a) and acute coronary syndrome: Associations with sex, age and traditional cardiovascular risk factors
Cross-sectional study of 388 peopleLipoprotein
Wednesday, March 25
Cardiovascular & Hematological Disorders Drug Targets
Lowering of Lipoprotein(a) with Olpasiran
ReviewInterventions
Monday, March 23
Clinical Research in Cardiology
Modulation of oxidation-related immune markers by lipid-lowering medications in individuals with elevated lipoprotein(a)
Non-randomized trial in 70 peopleInterventions
Frontiers in Cardiovascular Medicine
Exploratory observational study with Two-year outcomes of early in-hospital evolocumab in acute coronary syndrome patients undergoing coronary artery bypass grafting
Cohort study of 74 peopleEvolocumab
Friday, March 20
Medicine
Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study
Mendelian randomization in peopleEpilepsy
Journal of Cardiovascular Medicine
Inclisiran safety and efficacy in real-world clinical practice: results of a retrospective observational investigation
Cohort study in peopleInclisiran
Friday, March 13
Catheterization and Cardiovascular Interventions
Plaque Morphology-Dependent Regression of Tandem Coronary Plaques Under Intensive Lipid-Lowering Therapy
Case reportInterventions
Journal of Clinical Lipidology
Bempedoic acid vs ezetimibe added to statin therapy: Cardiovascular outcomes in the real-world-The BEYOND-REAL Study
Cohort study of 6,706 peopleBempedoic acid
Thursday, March 12
The Journal of the Association of Physicians of India
Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study
Randomized trial in 254 peopleEzetimibe
The American Journal of Medicine
Ten reasons to treat all individuals with a positive coronary artery calcium score
ReviewCoronary artery disease
Tuesday, February 24
Annals of Medicine
Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events
CommentaryEzetimibe
Monday, January 19
European Journal of Preventive Cardiology
Lipid-lowering therapy for cardiovascular risk management in the older patients: how far should we go?
ReviewCardiovascular disease
Tuesday, December 16
Current Cardiology Reports
Lipid-Lowering Therapies and Cognition in Older Adults: A Narrative Review and Clinical Considerations
ReviewInterventions
Wednesday, December 10
Thursday, November 27
Current Cardiology Reports
Life Course Approach to Familial Hypercholesterolemia
Monday, November 3
AHA Scientific Sessions 2025 Abstract
Safety and Efficacy of Moderate-Intensity Statin Plus Ezetimibe versus High-Intensity Statin in Older Adult Patients: A Meta-analysis
Meta-analysis of randomized trialsEzetimibe
AHA Scientific Sessions 2025 Abstract
FRAGILITY INDICES OF LIPID-LOWERING RANDOMIZED CONTROLLED TRIALS
Computational studyInterventions
AHA Scientific Sessions 2025 Abstract
Aggressive Lipid Lowering Differentially Impacts the Vascular Endothelium in Diabetic vs Healthy Individuals. Findings from the American Heart Association Cardiometabolic Health Strategically Focused Research Network
Non-randomized trial in 25 peopleInterventions
AHA Scientific Sessions 2025 Abstract
Direct Vascular Endothelial Assessment Highlights the Pleotropic Anti-Inflammatory Properties of Statin Therapy: Findings from the American Heart Association Cardiometabolic Health Strategically Focused Research Network
Non-randomized trial in 24 peopleStatins
AHA Scientific Sessions 2025 Abstract
Evaluating Lipid-Lowering Efficacy Of Obicetrapib: An Updated Meta-Analysis of Clinical Trials
Meta-analysisObicetrapib
AHA Scientific Sessions 2025 Abstract
Cholesteryl Ester Transfer Protein (CETP) Inhibition with Obicetrapib Produces Substantial Reductions in LDL Particles: Pooled Analysis of BROOKLYN and BROADWAY Phase 3 Clinical Trials
Randomized trial in 2,024 peopleObicetrapib
AHA Scientific Sessions 2025 Abstract
Impact of the Lipid-Lowering Therapy on the Distribution Differences Between Lipid Fractions
Cross-sectional study of 5,047 peopleLipid-lowering therapy